Manuscripts
Showing 1544 manuscripts.
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study
Citation
Mark F Cotton, Patrick Jean-Philippe, Anne Coletti, Ellen G Chadwick, Jennifer Jao, Stephen A Spector, Mark Mirochnick, Edmund V Capparelli, Diane Costello, Joseph Szewczyk, Nicol Nicodimus, Lynda Stranix-Chibanda, Adeodata R Kekitiinwa, Violet Korutaro, Deborah Persaud, Christina Reding, Yvonne Bryson, Mary N Carrington, Bryan S Nelson, Sai Majji, Camlin Tierney, Dwight E Yin. HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study. Lancet HIV. 2024. 23: 2352-3018. PMID: 38061376Year
2024
Journal
Lancet HIV
Study
P1115
Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum
Citation
Lauren Ziemba, Rebecca Zash, Lameck Chinula, Roger Shapiro, Jeffrey S A Stringer, Nahida Chakhtoura, Frances Nakayiwa, Ben Johnston, Avy Violari, Chelsea Krotje, Lee Fairlie, Katie McCarthy, Victoria Ndyanabangi, Patrick Jean-Philippe, Teacler G. Nematadzira, Paul Sax, Sherika Hanley, Judith S. Currier, Esau João, Shahin Lockman, Linda Aurpibul, VESTED Study Team, Mario Dias Correa Junior, Oranich Navanukroh, Neetal Nevrekar, Risa M. Hoffman, Gerhard Theron, Sean Brummel, Cristina Barroso Hofer. Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum. Clinical Infectious Diseases. 2024. ciae001PMID: 38180851Year
2024
Journal
Clinical Infectious Diseases
Study
IMPAACT 2010
Impact of In-Utero Exposure to HIV and Latent TB on Infant Humoral Reponses
Citation
Kimberly J.S. Hjelmar, Lesley R. de Armas, Evan Goldberg, Suresh Pallikkuth, Jyoti Mathad, Grace Montepiedra, Amita Gupta, Savita Pahwa. Impact of In-Utero Exposure to HIV and Latent TB on Infant Humoral Reponses. Frontiers in Immunology. 2024. 15: 1423435. PMID: 38994354Year
2024
Journal
Frontiers in Immunology
Study
P1078
Characterising HIV drug resistance in cases of vertical transmission in the VESTED randomised antiretroviral treatment trial
Citation
Ceejay L. Boyce, Lisa M. Frenkel, Ingrid A. Beck, IMPAACT 2010 Team, Sheila M. Styrchak, Kevin Knowles, Lauren Ziemba, Sean Bremmel, Anne Coletti, Patrick Jean Philippe, Nahida Chakhtoura, Tichaona Vhembo, Haseena Cassim, Maxensia Owor, Lee Fairlie, Sikhulile Moyo, Violet Korutaro, Lameck Chinula, Marley D. Bishop, Shahin Lockman. Characterising HIV drug resistance in cases of vertical transmission in the VESTED randomised antiretroviral treatment trial. Journal of International AIDS Society. 2024. 96: 385-392.Year
2024
Journal
Journal of International AIDS Society
Study
IMPAACT 2010
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study
Citation
Kristin Baltrusaitis, Jenny Huang, Barbara Heckman, Sarah Buisson, Dwight E. Yin, Ryan Milligan, Allison Agwu, Shawn Ward, Rohan Hazra, Carolyn Bolton-Moore, Conn Harrington, Aditya H. Gaur, Rodica M. Van Solingen-Ristea, IMPAACT 2017 Team, Cynthia C. McCoig, Adeola Adeyeye, Jared Kneebone, Vasiliki Chounta, Christiana Smith-Anderson, Elizabeth D. Lowenthal, Andres Camacho-Gonzalez, Jennifer Chapman, Ellen Chadwick, Rachel Ohrenschall, Allison Bearden, Katherine Calabrese, Herta Crauwels. Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study. Lancet HIV. 2024. 11: e222-e232. PMID: 38538161Year
2024
Journal
Lancet HIV
Study
IMPAACT 2017
Infants Receiving Very Early ART Have High CD4 Counts in the First Year of Life
Citation
Deborah Persaud, Ellen G. Chadwick, Jennifer Jao, IMPAACT P1115 Team, Mark F. Cotton, Yvonne Bryson, Anne Coletti, Theodore D. Ruel, Stephen A. Spector, Christina Reding, Kira Bacon, Diane Costello, Charlotte Perlowski, Maria Leticia Santos Cruz, Josphat Kosgei, Sai Majji, Bryan S. Nelson, Dwight E. Yin, Camlin Tierney, Patrick Jean-Philippe. Infants Receiving Very Early ART Have High CD4 Counts in the First Year of Life. Clinical Infectious Diseases. 2023. 76: e744-e747. PMID: 36031390Year
2023
Journal
Clinical Infectious Diseases
Study
P1115
Pharmacokinetics, tolerability, and safety of doravirine and doravirine/lamivudine/tenofovir disoproxil fumarate fixed dose combination tablets in adolescents living with HIV: Week 24 results from IMPAACT 2014
Citation
Hong Wan, Hedy Teppler, Kathryn P Gray, Ellen Townley, Mounika Yedla, Jack Moye, Brookie M. Best, Nicole H. Tobin, IMPAACT 2014 Study Team, Havilland Campbell, Katie McCarthy, Rachel Scheckter, Linda Aurpibul, Pradthana Ounchanum, Supattra Rungmaitree, Hassena Cassim, Elizabeth McFarland, Patricia Flynn, Ann J Melvin, Ellen Cooper, Ka Lai Yee, Chelsea Krotje. Pharmacokinetics, tolerability, and safety of doravirine and doravirine/lamivudine/tenofovir disoproxil fumarate fixed dose combination tablets in adolescents living with HIV: Week 24 results from IMPAACT 2014. Journal of AIDS. 2023. PMID: 36215957Year
2023
Journal
Journal of AIDS
Study
IMPAACT 2014
Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and India
Citation
David E. Shapiro, Patience Atuhaire, Taha E Taha, Bonus Makanani, Lameck Chinula, Maxensia Owor, Dhayendre Moodley, Tsungai Chipato, Katie McCarthy, Patricia M. Flynn, Judith Currier, Mary Glenn Fowler, Amita Gupta, Nishi Suryavanshi, Neetal Nevrekar, Kevin Butler. Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and India. Journal of the International AIDS Society. 2023. 92: 76-83. PMID: 36170749Year
2023
Journal
Journal of the International AIDS Society
Study
1077FF, 1077BF
Physiologically-based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID-19
Citation
Kristina Brooks, Brookie M Best, Diana F Clarke, Mark Mirochnick, John N van den Anker, Edmund V Capparelli, Jeremiah D Momper, Xiaomei Liu, André Dallmann. Physiologically-based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID-19. CPT: pharmacometrics & systems pharmacology. 2023. 12: 148-153. PMID: 36479969Year
2023
Journal
CPT: pharmacometrics & systems pharmacology
Study
IMPAACT 2032
Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial
Citation
James Ngocho, Gift Chareka, Ponego Ponatshego, Gaerolwe Masheto, Katie McCarthy, Patrick Jean-Philippe, Amita Gupta, Lynda Stranix-Chibanda, IMPAACT P1078 TB APPRISE study team, Patricia Mandima, Kristin Baltrusaitis, Grace Montepiedra, Lisa Aaron, Jyoti Mathad, Carolyne Onyango-Makumbi, Mandisa Nyati. Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial. Journal of Acquired Immune Deficiency Syndromes. 2023. PMID: 36650479Year
2023
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1078